Literature DB >> 2026760

Suppression of counterregulatory hormone response to hypoglycemia by insulin per se.

M P Diamond1, L Hallarman, K Starick-Zych, T W Jones, M Connolly-Howard, W V Tamborlane, R S Sherwin.   

Abstract

Although assessment of counterregulatory hormone responses to hypoglycemia relies upon insulin to lower the glucose level, it is not known if the exogenous insulin does used itself influences the magnitude of the hormone response. To assess this, 12 normal subjects randomly received 2 hypoglycemic clamp studies in which the only variable was the insulin dose (0.6 or 5.0 mU/kg-min). Despite 10-fold differences in circulating insulin (265 +/- 29 vs 2576 +/- 222 pmol/L respectively), the hypoglycemic stimulus did not vary. Glucose levels fell over one hour, and then were maintained for two hours at the same hypoglycemic plateau (approximately 3.1 mmol/L for each study) by a variable glucose infusion. Although basal counterregulatory hormone levels in low and high dose studies were indistinguishable, during hypoglycemia the response of epinephrine, growth hormone, and glucagon was significantly suppressed when the degree of hyperinsulinemia was increased. We conclude that raising the magnitude of hyperinsulinemia suppresses the magnitude of the counterregulatory hormone response to hypoglycemia in normal subjects. This modulating effect of insulin per se is yet another variable in the interpretation of hypoglycemic counterregulation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2026760     DOI: 10.1210/jcem-72-6-1388

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

Review 1.  Neuroendocrine responses to hypoglycemia.

Authors:  Nolawit Tesfaye; Elizabeth R Seaquist
Journal:  Ann N Y Acad Sci       Date:  2010-10-29       Impact factor: 5.691

2.  Human insulin and hypoglycaemia: burning issue or hot air?

Authors:  G Williams; A W Patrick
Journal:  BMJ       Date:  1992-08-08

Review 3.  Pancreatic Islet Transplantation in Humans: Recent Progress and Future Directions.

Authors:  Michael R Rickels; R Paul Robertson
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

Review 4.  Adverse effects of exogenous insulin. Clinical features, management and prevention.

Authors:  A W Patrick; G Williams
Journal:  Drug Saf       Date:  1993-06       Impact factor: 5.606

5.  Influence of insulin in the ventromedial hypothalamus on pancreatic glucagon secretion in vivo.

Authors:  Sachin A Paranjape; Owen Chan; Wanling Zhu; Adam M Horblitt; Ewan C McNay; James A Cresswell; Jonathan S Bogan; Rory J McCrimmon; Robert S Sherwin
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

6.  Brain insulin action regulates hypothalamic glucose sensing and the counterregulatory response to hypoglycemia.

Authors:  Kelly A Diggs-Andrews; Xuezhao Zhang; Zhentao Song; Dorit Daphna-Iken; Vanessa H Routh; Simon J Fisher
Journal:  Diabetes       Date:  2010-06-14       Impact factor: 9.461

7.  Glucagon administration elicits blunted GH but exaggerated ACTH response in obesity.

Authors:  F Tassone; S Grottoli; R Rossetto; B Maccagno; C Gauna; R Giordano; E Ghigo; M Maccario
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

8.  Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM.

Authors:  C Fanelli; S Pampanelli; L Epifano; A M Rambotti; A Di Vincenzo; F Modarelli; M Ciofetta; M Lepore; B Annibale; E Torlone
Journal:  Diabetologia       Date:  1994-12       Impact factor: 10.122

9.  Impaired hormonal responses to hypoglycemia in spontaneously diabetic and recurrently hypoglycemic rats. Reversibility and stimulus specificity of the deficits.

Authors:  A M Powell; R S Sherwin; G I Shulman
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

10.  Brain insulin infusion does not augment the counterregulatory response to hypoglycemia or glucoprivation.

Authors:  Kent K Ishihara; Samuel C Haywood; Dorit Daphna-Iken; Erwin C Puente; Simon J Fisher
Journal:  Metabolism       Date:  2009-06       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.